Omeprazole



Combined with:

Asa
Yaz

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 30.6%
Gastrooesophageal Reflux Disease 20.5%
Hypertension 7.9%
Dyspepsia 6.8%
Drug Use For Unknown Indication 6.0%
Prophylaxis 2.7%
Hiatus Hernia 2.6%
Gastritis 2.5%
Prophylaxis Against Gastrointestinal Ulcer 2.3%
Pain 2.2%
Barrett's Oesophagus 2.2%
Gastric Ulcer 1.9%
Abdominal Pain Upper 1.8%
Depression 1.8%
Helicobacter Infection 1.7%
Anxiety 1.4%
Asthma 1.3%
Reflux Oesophagitis 1.3%
Blood Cholesterol Increased 1.3%
Diabetes Mellitus 1.2%
Hypomagnesaemia 13.7%
Vomiting 10.7%
Renal Failure Acute 8.2%
Tubulointerstitial Nephritis 7.5%
Product Substitution Issue 7.0%
Drug Ineffective 6.5%
Urticaria 4.3%
Tetany 4.1%
Weight Decreased 4.0%
Drug Interaction 3.8%
Hyponatraemia 3.6%
Cutaneous Lupus Erythematosus 3.2%
Gastrooesophageal Reflux Disease 3.0%
Rash 3.0%
Rhabdomyolysis 3.0%
Weight Increased 3.0%
Nausea 2.9%
Diarrhoea 2.9%
Erectile Dysfunction 2.9%
Paraesthesia 2.8%
Secondary
Product Used For Unknown Indication 27.6%
Drug Use For Unknown Indication 16.6%
Gastrooesophageal Reflux Disease 16.6%
Hypertension 8.3%
Pain 4.6%
Depression 3.2%
Prophylaxis 2.4%
Dyspepsia 2.4%
Rheumatoid Arthritis 2.3%
Asthma 2.0%
Anxiety 1.7%
Type 2 Diabetes Mellitus 1.6%
Diabetes Mellitus 1.5%
Blood Cholesterol Increased 1.5%
Gastritis 1.4%
Helicobacter Infection 1.4%
Drug Abuse 1.4%
Hiatus Hernia 1.3%
Constipation 1.1%
Barrett's Oesophagus 1.1%
Tetany 11.5%
Vomiting 11.4%
Weight Decreased 8.4%
Drug Ineffective 6.9%
Toxic Epidermal Necrolysis 6.9%
Weight Increased 5.2%
White Blood Cell Count Increased 4.5%
Gastrooesophageal Reflux Disease 4.3%
Off Label Use 4.1%
Intentional Drug Misuse 3.9%
Thrombocytopenia 3.8%
Completed Suicide 3.7%
Stevens-johnson Syndrome 3.4%
Drug Dose Omission 3.4%
Malaise 3.3%
Rhabdomyolysis 3.1%
Death 3.1%
Hypomagnesaemia 3.1%
Renal Failure Acute 3.1%
Toxicity To Various Agents 3.0%
Concomitant
Product Used For Unknown Indication 32.3%
Drug Use For Unknown Indication 16.3%
Hypertension 8.2%
Rheumatoid Arthritis 7.7%
Prophylaxis 4.8%
Pain 4.8%
Gastrooesophageal Reflux Disease 3.3%
Depression 2.9%
Diabetes Mellitus 2.3%
Osteoporosis 2.2%
Multiple Myeloma 2.2%
Crohn's Disease 2.0%
Blood Cholesterol Increased 1.5%
Asthma 1.5%
Anxiety 1.5%
Atrial Fibrillation 1.4%
Chronic Obstructive Pulmonary Disease 1.3%
Hepatitis C 1.3%
Insomnia 1.2%
Nausea 1.2%
Vomiting 14.8%
Weight Decreased 8.2%
Pneumonia 5.6%
Weight Increased 5.6%
Renal Failure Acute 5.4%
Urinary Tract Infection 5.4%
Pyrexia 5.2%
Death 5.1%
Thrombocytopenia 4.5%
Nausea 4.5%
Pain 4.5%
Drug Ineffective 4.1%
Sepsis 3.7%
Dyspnoea 3.5%
Tremor 3.5%
Rash 3.4%
Renal Failure 3.4%
Pulmonary Embolism 3.3%
Myocardial Infarction 3.1%
White Blood Cell Count Decreased 3.1%
Interacting
Product Used For Unknown Indication 27.8%
Drug Use For Unknown Indication 14.3%
Hypertension 8.7%
Prophylaxis Against Gastrointestinal Ulcer 4.7%
Dyspepsia 4.4%
Pain 4.4%
Depression 3.6%
Gastrooesophageal Reflux Disease 3.6%
Bone Pain 3.4%
Osteoporosis 3.4%
Epilepsy 3.3%
Constipation 2.3%
Hyperlipidaemia 2.2%
Cardiac Disorder 2.1%
Helicobacter Infection 2.1%
Prophylaxis 2.1%
Rheumatoid Arthritis 2.1%
Thrombosis Prophylaxis 2.1%
Chemotherapy 2.0%
Atrial Fibrillation 1.8%
Drug Interaction 30.5%
Tremor 8.0%
Hypertension 6.4%
Vomiting 5.9%
Toxicity To Various Agents 4.8%
Respiratory Tract Congestion 4.3%
Transaminases Increased 4.3%
Hyponatraemia 3.7%
Thrombocythaemia 3.7%
Polymyositis 3.2%
Renal Tubular Acidosis 3.2%
Rhabdomyolysis 3.2%
Therapeutic Agent Toxicity 3.2%
Drug Resistance 2.7%
Pyrexia 2.7%
Potentiating Drug Interaction 2.1%
Supraventricular Tachycardia 2.1%
Vestibular Disorder 2.1%
Weight Increased 2.1%
Coagulopathy 1.6%